SEC Form 4 · accession 0001332438-15-000001
Adhera Therapeutics, Inc. · ATRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Michael French
Officer — President and CEO · Director
Period of report
Dec 30, 2014
Accepted (ET)
Jan 2, 2015 · 10:40 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000737207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 30, 2014 | F | 309,055 | $0.33 | D | 822,283 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were withheld by the issuer in connection with the satisfaction of tax withholding obligations arising in connection with the prior issuance of restricted shares of common stock.